EOM Pharmaceutical Holdings Inc. (IMUC)

[hotrod34racer]

These 3 Pharmaceutical Companies Control Roughly Half of All Cancer Drug Sales
Global cancer drug sales totaled $91 billion in 2013 and are expected to breach $100 billion in sales sooner than you think. Yet, three big pharmaceutical companies currently control about half of all cancer drug sales.

Who's not among the top 10 cancer drug developers in the world by sales? Some surprisingly big names, such as AbbVie, Biogen Idec, GlaxoSmithKline, Sanofi, and Pfizer. Of course, Pfizer's luck could change with the possible approval of palbociclib.

But, even more high-profile names are left out of the top three. Bristol-Myers Squibb, Merck, AstraZeneca, Eli Lilly, Johnson & Johnson, and Celgene make up spots nine through four. Combined, these six companies were responsible for $24.4 billion in cancer drug sales in 2013. Yet, the No. 1 company on the list sold more oncology drugs than these six companies combined!

Link